Navigation Links
Quark Pharmaceuticals Announces Poster Presentations at RNAi Europe 2008
Date:9/17/2008

es raises the necessity to target more than one gene at a time. At the same time, simultaneous delivery of different siRNAs targeting one and the same gene can increase the treatment specificity and reduce off-target effects.

Dr. Daniel Zurr, Quark's Chief Executive Officer, stated, "These poster presentations highlight our ongoing work to establish Quark's leadership in the field of RNAi by developing novel IP and expertise covering technology platforms that facilitate development of siRNA therapeutics. With the industry's most robust portfolio of siRNA therapeutics currently under evaluation in human clinical trials, Quark has proven its ability to advance siRNA products from discovery to the clinic."

About Quark Pharmaceuticals, Inc.

Quark Pharmaceuticals, Inc. is a development-stage pharmaceutical company engaged in discovering and developing novel therapeutic RNAi drug candidates. Quark has a fully integrated drug development platform that spans therapeutic target identification to drug development. Quark's RNAi technology includes novel siRNA structures and chemistry that the Company believes provide Quark with freedom to operate in the siRNA intellectual property arena, as well as the ability to deliver siRNA non invasively to organs including the eye, ear, kidney, lung, spinal cord and brain.

PF-4523655 (RTP801i-14), currently in Phase II clinical trials, is a synthetic, chemically modified, siRNA molecule to inhibit the expression of the gene RTP801, licensed to Pfizer. In addition, Quark's current clinical pipeline includes AKIi-5, developed by Quark for the prevention of acute kidney injury (AKI) following major cardiac surgery, currently in Phase I/IIa clinical trials via systemic delivery and DGFi with open IND for prevention of delayed graft function in kidney transplantation. Based on publicly available information, Quark believes AKIi-5 was the first siRNA delivered systemically in a human clinical trial.

In additio
'/>"/>

SOURCE Quark Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3

Related biology technology :

1. FDA Approves Quark IND for DGFi, an siRNA Therapeutic Based on Silence Therapeutics Unique Proprietary Chemistry
2. Quark Pharmaceuticals to Participate in 9th Annual Beyond Genome Conference
3. Cequent Pharmaceuticals Meets Novartis Option Fund Milestone; Continues to Next Phase to Validate Inflammatory Bowel Disease Targets in Vivo
4. David Hsia, Ph.D. Joins Kinex Pharmaceuticals Board of Directors
5. Trubion Pharmaceuticals Wins Patent Opposition - Genentech / Biogen Idec European Patent Revoked
6. Dr. Paul Korner Joins Ferring Pharmaceuticals as Vice President, Medical Affairs
7. Rib-X Pharmaceuticals, Inc. Announces Formation of Clinical Advisory Board
8. VIA Pharmaceuticals to Host Investor Science Briefing on the Role of Inflammation in Cardiovascular Disease on Tuesday, September 16
9. Peregrine Pharmaceuticals Reports Financial Results for the First Quarter of Fiscal Year 2009
10. Oramed Pharmaceuticals Partners With ETI Karle Clinical to Conduct Phase 2B Trials on Its Oral Insulin Capsule, ORMD 0801
11. Genesis Pharmaceuticals Completes Reverse Stock Split and Will Trade Under a New Symbol
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... -- New programme aims to help ... and chemical sectors Pfizer Asia Pacific ... Siemens Pte. Ltd, have signed on as founding ... - Innovative Processing of Specialties and Pharmaceuticals (iPSP). ... Sciences (ICES), the consortium offers a platform for ...
(Date:6/19/2013)... June 19, 2013 For an eco-friendly ... Waterless Bead Baths using metallic beads instead of ... and do not require germicides. Yet, the bead bath ... the bath is always ready unlike a water bath, ... a dry bath, which eliminates the contamination and maintenance ...
(Date:6/19/2013)... June 19, 2013 Bellevue city ... hall of technology solutions for people with disabilities ... Hyatt Regency Bellevue. , The exhibit hall, ... on Saturday and Sunday, will feature leading manufacturers ... wheelchairs, communication devices, eyegaze technologies, computer applications, and ...
(Date:6/19/2013)... An article posted earlier this week by Fox ... for probiotics. The article stated that while many products are ... beeb listed, the actual use for probiotics may go ... While the total uses of probiotics have not yet been ... these “miracle” bacterium, and debunked the myths surrounding them. ...
Breaking Biology Technology:Pfizer, GSK, and Siemens Form R&D Consortium With A*STAR's Institute of Chemical & Engineering Sciences 2Pfizer, GSK, and Siemens Form R&D Consortium With A*STAR's Institute of Chemical & Engineering Sciences 3Pfizer, GSK, and Siemens Form R&D Consortium With A*STAR's Institute of Chemical & Engineering Sciences 4Cole-Parmer Introduces Eco-Friendly Waterless Bead Baths 2City of Bellevue, Wash., Welcomes Assistive Technology Exhibit Hall 2Natural Acne Remedy, Probiotic Action Explains the Science behind Using Probiotics for Better Health 2
... Pharma, an emerging biotech,company focused on developing ... data demonstrating that its enzyme,replacement therapy (ERT) ... already been severely weakened by the disease. ... product ENB-0040, significantly,increases survival and prevents bone ...
... Commentary and How-To, Communications Tools; and ... ALTO, Calif., Sept. 15 Lena Chow, a ... has,launched a new website, http://www.cityofparis.us, to ... share thinking, gain insights and,connect with their peers. ...
... SHENYANG, China, Sept. 15 3SBio Inc. (Nasdaq:,SSRX), ... manufacturing and marketing biopharmaceutical products, today,announced the results ... General,Meeting of Shareholders held on September 12, 2008 ... meeting, the Company,s shareholders re-elected Dr. Jing Lou,Liping ...
Cached Biology Technology:Enobia Pharma Presents PreClinical Data Showing ENB-0040 Significantly Improved Survival and Healed Skeletal Manifestations of Severe Hypophosphatasia in Mice 2Enobia Pharma Presents PreClinical Data Showing ENB-0040 Significantly Improved Survival and Healed Skeletal Manifestations of Severe Hypophosphatasia in Mice 3
(Date:6/19/2013)... June 19, 2013   Mercy Medical ... diagnostics technology for conducting on-demand, Hemoglobin A ... as well as analysis of important red ... counts. The new system enables the hospital ... for physicians and their patients, which can ...
(Date:6/19/2013)... (SACRAMENTO, Calif.) A study of the patients ... fungus Exserohilum rostratum from the New England Compounding ... infections even though they did not experience a ... imaging (MRI) can help detect infection, especially among ... lots. , The study, along with an ...
(Date:6/19/2013)... Mass. In the cover story for the journal ... colleagues at the University of Massachusetts Amherst describe a ... to study the function of individual proteins in individual ... advance should allow deeper insights into protein function, Chase ... of what that single protein does when we isolate ...
Breaking Biology News(10 mins):Mercy Lab Offers Faster On-demand Diabetes Testing, Cellular Studies 2Mercy Lab Offers Faster On-demand Diabetes Testing, Cellular Studies 3Mercy Lab Offers Faster On-demand Diabetes Testing, Cellular Studies 4Evolution of an outbreak: Complications from contaminated steroid injections 2UMass Amherst researchers develop powerful new technique to study protein function 2UMass Amherst researchers develop powerful new technique to study protein function 3
... to predict the impact of climate change on the dengue ... that could help limit its spread. According to ... Ecological Society,s journal Functional Ecology , climate change and ... mosquito,s range. But human behaviour in the form of ...
... 2009. The Alfred Wegener Institute for Polar and ... the ongoing Polarstern expedition LOHAFEX". Independent scientific and ... Education and Research and the Federal Ministry for ... that the iron fertilisation experiment LOHAFEX is neither ...
... leading provider of,embedded speech solutions today announced the ... AG, according to SVOX CEO Volker Jantzen.,SVOX has ... developed,over 25 years, including the SpeechAdvance(TM) speech recognition ... majority of the Professional,Speech Processing Group,s employees will ...
Cached Biology News:Hoarding rainwater could 'dramatically' expand range of dengue-fever mosquito 2Polarstern expedition 'LOHAFEX' can be conducted 2Polarstern expedition 'LOHAFEX' can be conducted 3SVOX Acquires Speech Processing Unit of Siemens AG, Expands Into Speech Recognition and Speech Dialog 2
UNIVERSAL SCORECARD DNA, 1 EA. * Category: Reagents/Consumables....
mitochondrial proteins (human heart) for 2-D gel electrophoresis *5 mg/mL*...
... GeneMaths XT is undoubtedly the most complete ... advanced concept of layers and subsets makes ... layers for different data outputs, for example ... etc., as well as different subsets of ...
...
Biology Products: